European Thoracic Oncology Platform Competitors and Similar CompaniesClear all

European Thoracic Oncology Platform's competitors and similar companies include Psnresearch, Indivumed, Ranok Therapeutics and American Cancer Society.

	European Thoracic Oncology Platform Stiftung European Thoracic Oncology Platform (ETOP) is a foundation promoting exchange and research in the field of lung cancer.	Psnresearch Psnresearch is a provider of clinical development service.	Indivumed Indivumed is an oncology company developing individualized cancer therapy.	Ranok Therapeutics Ranok Therapeutics is a company that develops targeted protein degradation for novel therapeutics discovery and development.	American Cancer Society American Cancer Society (ACS) is an organization that specializes in cancer prevention.
Founding Date	Founding Date 2009	Founding Date 1997	Founding Date 2002	Founding Date 2018	Founding Date 1913
Type	Type Private	Type Private	Type Private	Type Private	Type Private
Tags	Tags Healthcare clinical research oncology therapy	Tags Healthcare clinical research oncology therapy	Tags Healthcare clinical research oncology therapy	Tags Healthcare clinical research oncology therapy	Tags Healthcare clinical research oncology therapy
Locations	Locations Bern, CH HQ	Locations Charlottesville, US HQ Crows Nest, AU Santiago, CL Glostrup, DK Lyon, FR München, DE Genova, IT see more	Locations Hamburg, DE HQ Frederick, US	Locations HQ	Locations Kennesaw, US HQ Hagatna, GU Arecibo, PR Caguas, PR Mayagüez, PR Ponce, PR San Juan, PR see more
Employees	Employees N/A	Employees 24	Employees 964% decrease	Employees 11	Employees 7,754
Financial
Revenue (est.)	Revenue (est.) CHF5.5m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) €13m (FY, 2020)	Revenue (est.) N/A	Revenue (est.) $768.1m (FY, 2021)
Cost of goods	Cost of goods CHF4.2m (FY, 2021)	Cost of goods N/A	Cost of goods €8.2m (FY, 2020)	Cost of goods N/A	Cost of goods $442.5m (FY, 2021)
Gross profit	Gross profit CHF1.3m (FY, 2021)	Gross profit N/A	Gross profit €4.8m (FY, 2020)	Gross profit N/A	Gross profit $325.6m (FY, 2021)
Net income	Net income CHF121k (FY, 2021)	Net income N/A	Net income (€21.2m) (FY, 2020)	Net income N/A	Net income $69.3m (FY, 2021)
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 48m (over 8 years ago)	Latest funding round $ 40m (almost 5 years ago)	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 48m	Total funding raised $ 40m	Total funding raised N/A